Home Newsletters Industry News Page 3

Industry News

Latest

A research paper from COGNANO with co-authors from Google on a large-scale dataset of antigen-antibody interactions was accepted by NeurIPS 2023

Admin - September 27, 2023

Can-Fite Novel Approach for the Treatment of Pancreatic Carcinoma with Namodenoson Receives Appreciation of the American Association of Cancer Research (AACR)

Deep Genomics Introduces the Most Advanced AI Foundation Model for RNA Disease Mechanisms and Candidate Therapeutics

Precision BioSciences Receives U.S. Patent Allowance Covering PBGENE-PMM for m.3243-Associated Mitochondrial Diseases

Kallyope Enters Phase 2 With First-in-class Oral Approach for the Treatment of Both Obesity and Type 2 Diabetes

Alto Neuroscience Announces Positive Results from Phase 2 Study of ALTO-100...

Admin - September 26, 2023 0

Cytel continues expansion of market access and medical communication capabilities with...

Admin - September 26, 2023 0

Longhorn Vaccines and Diagnostics Presents Data Demonstrating Neutralizing Activity of LHNVD-201...

Admin - September 25, 2023 0

Lantern Pharma Announces First Patient Dosed in the Phase 1 Study...

Admin - September 25, 2023 0

Tris Pharma Secures First ex-US Authorizations for Quillivant ER Oral Suspension...

Admin - September 25, 2023 0

OJJAARA™ (momelotinib) Now Available from Onco360 For the Treatment of Intermediate...

Admin - September 25, 2023 0

Aviceda To Present at Major European Healthcare Conferences Highlighting AVD-104, a...

Admin - September 25, 2023 0

Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the...

Admin - September 25, 2023 0

Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262, a First-in-Class Oral...

Admin - September 25, 2023 0

Merck Announces Phase 3 KEYNOTE-A39/EV-302 Trial Met Dual Primary Endpoints of...

Admin - September 22, 2023 0

1 234...22 Page 3 of 22